“Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study” (2024) Biomolecules and Biomedicine [Preprint]. doi:10.17305/bb.2024.10512.